Take control of your life!
You did not choose to get cancer.
But you can choose to get involved in your treatment.
|I-FIND||Find ALL treatment options personalized for you. Standard of care, clinical trials and other promising therapies - all in one place. Short list of your best options today. More...|
|I-SHARE||No matter what treatment you choose, your clinical data is valuable. Document your treatments and outcomes using our web-based system. Use this system to monitor your progress or to get a second opinion. Pool your data with others like you to find treatments that work. More …|
|I-FUND||Fund clinical trials of IMMEDIATELY available promising treatments. More …|
GlobalCures is a non-profit medical research organization with a mission to help patients find their best treatment options today, share their clinical outcomes and fund promising therapies.
Billions of dollars are spent each year on laboratory research, where enormous progress has been made in recent years. However, for the most part, only those basic science discoveries with high potential for financial reward have led to drugs for human use leaving behind many untapped opportunities.
Among these financially unrewarding promising therapies (“Fiscal Orphans”), are many FDA approved drugs which are immediately available for use for diseases other than what they were approved for. In addition, many generally regarded as safe (GRAS) substances like flax oil or nutraceuticals such as vitamin C have been studied in humans but have rarely undergone rigorous clinical trials and therefore are typically not recommended by physicians as treatment options.
GlobalCures believes that we now have a unique opportunity - indeed a responsibility - to research further and develop such therapies.
Our Unique Business Model:
The current for-profit model used by pharmaceutical companies was necessary to develop the many promising drugs that GlobalCures will 'reposition' for a different use.
GlobalCures has adopted a non-profit drug development model, so that the criteria used in evaluating the potential of a therapy will focus solely on scientific merit and not on financial reward.